CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Ownership & governance
Executives 5Directors 10Avg age 62Avg tenure 5.6y
BG
Birgit Girshick
Chief Executive Officer
Age 56Since 2026-05-04Profile →
+14
Executives5
Board of directors10
JF
James Foster→
Chairman
Age 75Since 1999-12-31
BG
Birgit Girshick→
Director/Board Member
Age 56Since 2026-05-04
MM
Martin MacKay→
Chairman
Age 69Since 2026-05-04
VW
Virginia Wilson→
Director/Board Member
Age 71Since 2019-09-30
NA
Nancy Andrews→
Director/Board Member
Age 67Since 2020-02-27
GL
George Llado→
Director/Board Member
Age 60Since 2020-10-15
CT
Craig Thompson→
Director/Board Member
Age 73Since 2013-12-02
RK
Reshema Kemps-Polanco→
Director/Board Member
Age 53Since 2024-01-21
Shareholders4
| Name | Stake | Shares |
|---|---|---|
| Fidelity Management & Research Co. LLC | 7.175 % | 3,456,244 |
| BlackRock Advisors LLC | 6.927 % | 3,336,597 |
| Vanguard Capital Management LLC | 6.648 % | 3,202,204 |
| Invesco Advisers, Inc. | 4.977 % | 2,397,252 |
Catalog · 2026-07-09
Registry officers15
| Name | Role | Since | Shares |
|---|---|---|---|
| Birgit Girshick | Chief Executive Officer | 2026-05-04 | - |
| Glenn Coleman | Director of Finance/CFO | 2026-04-05 | - |
| James Foster | Chairman | 1999-12-31 | - |
| Mark Mintz | Chief Tech/Sci/R&D Officer | 2021-01-31 | - |
| Martin MacKay | Chairman | 2026-05-04 | - |
| Namandje Bumpus | Chief Tech/Sci/R&D Officer | 2026-01-11 | - |
| Birgit Girshick | Director/Board Member | 2026-05-04 | - |
| Craig Thompson | Director/Board Member | 2013-12-02 | - |
Registry · as of 2026-07-09
Group companies
| Name | Category |
|---|---|
| Charles River Laboratories India Pvt Ltd. | Pharmaceuticals: Major |
| Charles River UK Ltd. | Miscellaneous Commercial Services |
| Charles River Laboratories Luxembourg SARL | Miscellaneous Commercial Services |
| Charles River Laboratories, Inc. | Miscellaneous Commercial Services |
| Charles River Laboratories, Inc. | Miscellaneous Commercial Services |
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus buyMean target 315.53Range 145–357Analysts 15
145Mean 315.53357
- Strong buy 4
- Buy 11
- Hold 2
- Sell 1
Broker actions40 of 276
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| Morgan Stanley | Maintained | Overweight | 340 | 2026-10-13 |
| Jefferies | Maintained | Buy | 340 | 2026-09-28 |
| Deutsche Bank | Maintained | Buy | 320 | 2026-09-25 |
| TD Cowen | Maintained | Buy | 325 | 2026-09-25 |
| Evercore ISI Group | Maintained | Outperform | 330 | 2026-09-25 |
| RBC Capital | Maintained | Outperform | 322 | 2026-09-25 |
| Barclays | Maintained | Overweight | 330 | 2026-09-25 |
| Mizuho | Maintained | Neutral | 295 | 2026-09-25 |
| Baird | Maintained | Outperform | 334 | 2026-09-25 |
| Evercore ISI Group | Maintained | Outperform | 320 | 2026-09-11 |
| TD Cowen | Maintained | Buy | 300 | 2026-08-10 |
| Morgan Stanley | Maintained | Overweight | 300 | 2026-08-07 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.